<code id='6449D6BC33'></code><style id='6449D6BC33'></style>
    • <acronym id='6449D6BC33'></acronym>
      <center id='6449D6BC33'><center id='6449D6BC33'><tfoot id='6449D6BC33'></tfoot></center><abbr id='6449D6BC33'><dir id='6449D6BC33'><tfoot id='6449D6BC33'></tfoot><noframes id='6449D6BC33'>

    • <optgroup id='6449D6BC33'><strike id='6449D6BC33'><sup id='6449D6BC33'></sup></strike><code id='6449D6BC33'></code></optgroup>
        1. <b id='6449D6BC33'><label id='6449D6BC33'><select id='6449D6BC33'><dt id='6449D6BC33'><span id='6449D6BC33'></span></dt></select></label></b><u id='6449D6BC33'></u>
          <i id='6449D6BC33'><strike id='6449D6BC33'><tt id='6449D6BC33'><pre id='6449D6BC33'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:6853
          Stain of a biopsy specimen of a rhabdoid tumor -- health coverage from STAT
          Stain of a biopsy specimen of a rhabdoid tumor. Wikimedia Commons

          Most targeted cancer drugs work like tranquilizer darts, snaring an overzealous gene that has spurred the cell into murderously rapid growth.

          But many tumors don’t have a hyperactive gene. Like the mayhem in “Cat in the Hat,” they are enabled by parental absence. They grow because the genes that are meant to provide discipline, guiding the activity of other genes or self-destructing a cell whose DNA is too damaged, are broken or missing.

          advertisement

          These tumors have bedeviled researchers for decades. Restoring or fixing a protein is far harder than breaking it. And that’s bad news for humanity: Cancer is far more likely to be caused by such “tumor-suppressor” genes than by one gene run amok. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Pioneering cancer drug will cost $475,000. Analysts call it a bargain
          Pioneering cancer drug will cost $475,000. Analysts call it a bargain

          VictorSeguraIbarraandRitaSerda,Ph.D.,NCI,NIHTheFoodandDrugAdministrationonWednesdayapprovedafuturist

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          Physician executives need more than on

          AdobeItshouldbeobviousthatmedicalschoolandclinicalexperience,inthemselves,can’tfullypreparesomeonefo